Photoresponsive materials offer excellent spatiotemporal control over biological processes
and the emerging phototherapeutic methods are expected to have significant effects
on targeted cancer therapies. Recent examples show that combination of photoactivatable
approaches with bioorthogonal chemistry enhances the precision of targeted phototherapies
and profound implications are foreseen particularly in the treatment of disperse/diffuse
tumors. The extra level of on‐target selectivity and improved spatial/temporal control
considerably intensified related bioorthogonally assisted phototherapy research. The
anticipated growth of further developments in the field justifies the timeliness of
a brief summary of the state of the art.
